Email this article 
Review Articles
Gastro-oesophageal reflux: an overview of the pharmacotherapeutic treatment options
South African Family Practice | Vol 59, No 3 : May/June| a4687 |
DOI: https://doi.org/10.4102/safp.v59i3.4687
| ©
Submitted: 15 May 2017 | Published:
Submitted: 15 May 2017 | Published:
About the author(s)
L Malan, Sefako Makgatho Health Sciences University, South AfricaQ Labuschagne, Sefako Makgatho Health Sciences University, South Africa
N Schellack, Sefako Makgatho Health Sciences University, South Africa
G Schellack,, South Africa
J C Meyer, Sefako Makgatho Health Sciences University, South Africa
Full Text:
PDF (208KB)Abstract
Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relief. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents and pro-motility agents. Deciding on appropriate therapy will depend on the diagnosis, side-effects and cost-effectiveness of the treatment.
Keywords
GORD; gastro-oesophageal reflux; PPIs; proton-pump inhibitors
Metrics
Total abstract views: 2616Total article views: 927